A Single Center Study to Demonstrate the Safety and Performance of Lifelight® First Software Application
A Single-Center Study To Demonstrate the Safety and Performance of Lifelight® First Software Application - A Non-invasive Vital Signs Monitoring Device
1 other identifier
observational
85
1 country
1
Brief Summary
This study validates Lifelight® First, a software application, in a laboratory setting. Participants will undergo testing to obtain measurements from one or more of the four vital signs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2019
CompletedFirst Submitted
Initial submission to the registry
May 13, 2019
CompletedFirst Posted
Study publicly available on registry
June 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedJuly 26, 2021
July 1, 2021
2 years
May 13, 2019
July 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Blood Pressure Readings Validation
Agreement of Lifelight® First standard of care and range for blood pressure as per ISO 81060-2-Non-invasive-sphygmomanometers-Part 2-Clinical validation of automated measurement type
Single Visit; up to one day
Oxygen Saturation Readings Validation
Agreement of Lifelight® First standard of care and range for oxygen saturation as per ISO 80601-2-61-Medical electrical equipment-Part 2-61:Particular requirements for basic safety and essential performance of pulse oximeter equipment
Single Visit; up to one day
Heart Rate (pulse) Readings Validation
Agreement of Lifelight® First standard of care and range for heart rate (pulse) function as per ISO 80601-2-61- Particular requirements for basic safety and essential performance of pulse oximeter equipment
Single Visit; up to one day
Respiratory Rate Readings Validation
Agreement of Lifelight® First standard of care and range for respiratory rate by manually counting chest rises.
Single Visit; up to one day
Study Arms (4)
Oxygen Saturation (Oximetry)
Arm to determine the performance of the Oxygen Saturation measurement in LifeLight First
Heart Rate (Pulse)
Arm to determine the performance of the Heart Rate measurement in LifeLight First
Respiratory Rate
Arm to determine the performance of the Respiratory Rate measurement in LifeLight First
Blood Pressure
Arm to determine the performance of the Blood Pressure measurement in LifeLight First
Interventions
Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers
Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers
Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers
Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers For participants only participating in the Blood Pressure Arm of the trial, they will not be required to enter the normobaric chamber but will have their blood pressure readings taken in the ambient environment including lying supine in order to generate hypotensive readings.
Eligibility Criteria
The inclusion/exclusion criteria is limited to the intended use of the device, therefore only individuals, of any sex, over the age of 18 will be included in the study. The individuals for the purpose of the study have to be able to perform physical activity in the form of the ergometer if they are undertaking the exercise component.
You may qualify if:
- Subject is informed and has been given ample time and opportunity to think about his/her participation and has given his/her written informed consent
- Subject is ≥18 years of age
- Subject's health status: individual is considered to be healthy (hypertension and hypotension is permissible. Other stable diseases at the time of testing are also permissible)
- Subject is capable of undergoing controlled hypoxaemia to the levels called for the in the protocol with minimal medical risk (unless only participating in the blood pressure study).
You may not qualify if:
- Subject cannot expose their face fully for a reading to be taken
- Subject is unable to give informed consent
- Subject is outside of the specified age range
- Subject has already taken part in the study (all 4 sub studies)
- Subject with significant irregular heart rhythm or any disease that might affect the results of the study
- Subject is not capable of undergoing controlled hypoxia and would be placed at undue medical risk if this occurred
- Subject has any contraindications identified that would deem them unsuitable to take part
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xim Limitedlead
- University of Portsmouthcollaborator
Study Sites (1)
University of Portsmouth, Department of Sport and Exercise Science
Portsmouth, England, PO1 2HY, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2019
First Posted
June 25, 2019
Study Start
April 29, 2019
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
July 26, 2021
Record last verified: 2021-07